___

• U.S.Department of Health and Human Services. Reproductive impairment among married couples. In U.S.Vital Health Statistics Series 23,11. Hyattsville, MD: National Center of Health Statististics
• American Collage of Obstetricans and Gynecolists Practice Bulletin. Management of recurrent pregnancy loss. Number 24, 2001. Int Gynecol Obstet 2002;78(2):l79--90.
• Daya S. Evaluation and management of recurrent spontaneous abortion. Curr OpinObstet Gynecol. 1993;8(3):188--92.
• Katz VL, Kuller A. Recurrent miscarriage. Am Perinatol. 1994;11(6):386--97.
• Teremmahi Ardestani M, Nodushan HH, Aflatoonian A, Ghasemi N, Sheikhha MH. Case control study of the factor Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss. Iran Reprod Med 2013;l l(1):61--4.
• Martinez--Zamora MA, Cervera R, Balasch J. Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease. Clin Rev Allergy Immunol. 2012;43(3):265 --74.
• Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ. l989;299(6698):541--5.
• Stephenson MD, Awartini KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscariageza case--control study. Hum Reprod. 2002; 17(2) :446--51
• Boue J, Boue A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions.1975. Birth Defects Res Clin Mol Teratol. 2013;97(7):471--86.
• Hassolds TJ, Chen N, Funkhouser T, Jooss T, Manuel B, Matsuura J, Matsuyama A, Wilson C, Yamane JA, Jacobs PA. cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet. 1980;44(Pt2)2151--78
• Tharapel AT, Tharapel SA, Bannerman RM. Recurrent pregnancy losses and parenteral chromosome abnormalites: review. Br Obstet Gynecol. 1985;92(9):899
• Sugiura--Ogasawara M, Ozaki Y, Katano K, Suzumori N, Mizutani E. Uterine anomaly and recurrent pregnancy loss. Semin Reprod Med. 2011;29(6):514--21.
• Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Rep Update. 2000;6(6):614--20.
• Hart R, Khalaf Y, Yeong CT, Seed P, Taylor A, Braude P. prospective controlled study of the effect of intramural uterine fibroids on the outcome of asisted conception. Hum Rep. 2001;16(1 l):241 1--7.
• Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):375--90.
• Wilkowska--Troiniel M, Zdrodowska--Stefanow B, Ostaszewska--Puchalska l, Rediko S, Przepies'é J, Zdrodowski M. The influence of Chlamydia trachomatis infection on spontaneous abortions. Adv Med Sci. 2009;54(1):86--90.
• Clifford K, Rai R, Watson ve Regan L. An informative protocol for the investigation of recurrent miscariage: prelliminary experience of 500 consecutive cases. Hum Reprod. 1994;9(7):1328--32.
• Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscariage: reappraisal. Hum Reprod. 2000; 15(3):612--5
• Li TC, Spuijbroek MDEH, Tuckerman E, Anstie B, Loxley M, Laird SM. Endocrinological and endometrial factors in recurrent miscariage. Br Obstet Gynecol. 2000;107(12):1975--80.
• Chakraborty P, Goswami SK, Rajani S, Shanna S, Kabir SN, Chakravarty B, Jana K. Recurrent pregnancy loss in polycystic ovary syndrome: Role of hyperhomocysteinemia and insulin resistance. PLoS One. 2013;8(5):e64446.
• Li ZL, Xiang HF, Cheng LH, Cao YX, Wei ZL, Liu C, Hu JJ, Pan FM. Association between recurrent miscarriages and insulin resistance: meta analysis. Zhonghua Fu Chan Ke Za Zhi. 2012;47(12):915--9.
• Hong Y, Xie QX, Chen CY, Yang C, Li YZ, Chen DM, Xie MQ. Insulin resistance in first--trimester pregnant women with pre--pregnant glucose tolerance and history of recurrent spontaneous abortion. Biol Regul Homeost Agents. 2013;27(1):225--31.
• Okon MA, Laird SM, Tuckerman E, Li TC. Serum androgen levels in women who suffer recurrent miscariage and their correlation with markers of endometrial function. Fertil Steril. 1998;69(4):682--90.
• Bussen S, Sutterlin M, Steck T. Endocrine abnormalites during the folliculer phase in women with recurrent spontanous abortions. Hum Reprod. 1999;14(1):18--20.
• Watson H, Francks S, Bonney RC. Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture. Hum Rep. 1998; 13(9):25 85 --91.
• Tuckerman EM, Okon MA, Li TC, Laird SM. Do androgens have direct effect on endometrial function? An in vitro study. Fertil Steril. 2000;74(4):771--9
• Noyes RW, Hertig AT, Rock J. Dating the endometrisl biopsy. Am Obstet Gynecol. 1975;122(2):262--3.
• Li TC, Tuckerman E, Laird SM. Endometrial factors in recurrent miscariage. Hum Reprod Uptake. 2002;8(1):43--52
• Yan J, Sripada S, Saravelos SH, Chen ZJ, Egner W, Li TC. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: Prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril. 2012;98(2):378--82.
• Saito S, Nakashima A, Shima T. Future directions of studies for recurrent miscarriage associated with immune etiologies. Reprod Immunol. 2011;90(1):91--5.
• Russell P, Anderson L, Lieberman D, Tremellen K, Yilmaz H, Cheerala B, Sacks G. The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure I: Techniques. Reprod Immunol. 2011;91(l-- 2):90--102.
• Reus AD, van Besouw NM, Molenaar NM, Steegers EA, Visser W, de Kuiper RP, de Krijger RR, Roelen DL, Exalto N. An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss. Am Reprod Immunol. 2013;70(3):230--7.
• Christiansen OB. Reproductive immunology. Mol Immunol. 2013;55(1):8--15.
• Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Guijn HP. Final resuts of the Cervikal Incompetence Preventation Randomized Cerclage Trial (CIRPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am Obstet Gynecol. 2001;185(5):1106--12
• McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: An update. Curr Opin Obstet Gynecol. 2012;24(4):229--34.
• Branch DW, Gibson M, Silver RM. Clinical practice. Recurrent miscarriage. Engl Med. 2010;363(18):1740--7.
• Galli M, Finazzi G, Bevers EM, Barbui T. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin--dependent and beta 2-- glycoprotein I--dependent antiphospholipid antibodies. Blood. 1995;86(2):617--23.
• Rand JH, Wolgast LR. Dos and don'ts in diagnosing antiphospholipid syndrome.Hematology Am Soc Hematol Educ Program. 2012. 2012:455--9.
• Kutteh WH. Antiphospholipid antibody--associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low--dose aspirin alone. Am Obstet Gynecol. 1996;174(5):1584--9.
• Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: systemic review of therapeutic trials. Obstet Gynecol. 2002;99(1):1335--44.
• Middeldorp S. Is thrombophilia testing useful? Hematology Am Soc Hematol Educ Program. 2011. 2011:150--5.
• Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: systematic review. Br Haematol. 2006;132(2):171-96.
• Dizon--Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G, Jr, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ, Gabbe SG; National Institute of Child Health and Human Development Matemal--Fetal Medicine Units Network. The relationship of the factor Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106(3):5 17--24.
• Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G, Jr, Wenstrom K, Samuels P, Caritis SN, Sorokin Y, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal--Fetal Medicine Units (NlCHD MFMU) Network.. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol. 2010;115(l):l4--20.
• Said JM, Higgins JR, Moses EK, Walker SP, Borg AJ, Monagle PT, Brennecke SP. lnherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol. 2010;l l5(l):5--l3.
• de Jong PG, Goddijn M, Middeldorp S. Testing for inherited thrombophilia in recurrent miscarriage. Semin Reprod Med. 2011;29(6):540--7.
• Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: Biological and clinical implications.Reprod Biol Endocrinol. 2004;2:7.
• van der Put NM, Gabreöls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural--tube defects? Am Hum Genet. l998;62(5):lO44--5 l.
• Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. candidate genetic risk factor for vascular disease: common mutation in methylenetetrahydrofolate reductase. Nat Genet. l995;lO(l):l 1--3.
• Steegers--Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. Neural--tube defects and derangement of homocysteine metabolism. Engl Med. l99l;324(3):l99--200.
• Steegers--Theunissen RP, Boers GH, Blom HJ, Trijbels FJ, Eskes TK. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet. l992;339(8801):1122--3.
• Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: meta--analysis. Fertil Steril. 2000;74(6):l 196-- 9.
• Carrell DT, Liu L, Peterson CM, Jones KP, Hatasaka HH, Erickson L, Campbell B. Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl. 2003;49(l):49--55.
• Brahem S, Mehdi M, Landolsi H, Mougou S, Elghezal H, Saad A. Semen parameters and sperm DNA fragmentation as causes of recurrent pregnancy loss. Urology. 2011;78(4):792--6.
• Ribas--Maynou J, Garcia--Peiro A, Fernandez--Encinas A, Amengual MJ Prada E, Cortes P, Navarro J, Benet J. Double stranded sperm DNA breaks, measured by Comet assay, are associated with unexplained recurrent miscarriage in couples without female factor. PLoS One. 2012;7(9):e44679.
• Dul EC, van Echten--Arends J, Groen H, Dijkhuizen T, Land JA, van Ravenswaaij-- Arts CM. Chromosomal abnormalities in azoospermic and non--azoospermic infertile men: Numbers needed to be screened to prevent adverse pregnancy outcomes. Hum Reprod.2012;27(9):2850--6.
• Stray--Pedersen B, Stray--Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with prior history of habitual abortion. Am Obstet Gynecol. 1984;148(2):l40--6.
• Rumbold A, Middleton P, Pan N, Crowther CA. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev. 2011;1:CD004073.
• Twisk M, Mastenbroek S, Hoek A, Heineman MJ van der Veen F, Bossuyt PM, Repping S, Korevaar C. No beneficial effect of preimplantation genetic screening in women of advanced maternal age with high risk for embryonic aneuploidy. Hum Reprod. 2008;23(12):2813--7.
• Otani T, Roche M, Mizuike M, Colls P, Escudero T, Munne' S. Preimplantation genetic diagnosis significantly improves the pregnancy outcome of translocation carriers with history of recurrent miscarriage and unsuccessful pregnancies. Reprod Biomed Online. 2006;13(6):869--74.
• Brix N, Secher NJ, McCormack CD, Helmig RB, Hein M, Weber T, Mittal S, Kurdi W, Palacio M, Henriksen TB; CERVO group. Randomised trial of cervical cerclage, with and without occlusion, for the prevention of preterm birth in women suspected for cervical insufficiency. BJOG. 2013;120(5):613-20.
• Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: randomised controlled trial. Lancet. 2003 ;361(9362):983--8.
• Mills JL, Simpson JL, Driscoll SG, ovanovic--Peterson L, Van Allen M, Aarons JH, Metzger B, Bieber FR, Knopp RH, Holmes LB, et al. Incidence of spontaneous abortion among normal women and insulin--dependent diabetic women whose pregnancies were identified within 21 days of conception. Engl Med. 1988;319(25):1617-23.
• Hanson U, Persson B, Thunell S. Relationship between haemoglobin AlC in early type (insulin--dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia. 1990;33(2):100--4.
• Craig LB, Ke RW, Kutteh WH. Incresaed prevalance of insulin resistance in women with history recurrent pregnancy loss. Fertil Steril 2002;78(3):487--90.
• Carrington B, Sacks G, Regan L. Recurrent miscarriage: Pathophysiology and outcome. Curr Opin Obstet Gynecol. 2005 ;l7(6):591-7.
• Glueck CJ, Streicher P, Wang P. Treatment of polycystic ovary syndrome with insulin--lowering agents. Expert Opin Pharmacother. 2002;3(8):1177--89.
• Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. l998;70(2):246--52.
• Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2008;22CD003511.
• Oates--Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2003;4zCD003511.
• Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. meta--analysis of controlled trials. Br Obstet Gynaecol. l989;96(3):275--80.
• Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscariage associated with phospholipid antibodies (or antiphospholipd antibodies). Br Med J. l997;3l4(7076):253--257.
• Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br Haematol. 2000;109(4):704--15.
• Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am Obstet Gynecol. l989;l60(2):439--43.
• Brenner B, Hoffman R, Blumenfeld Z. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated with enoxaparin. Thromb Haemost. 2000;83(5):693--7.
• Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. Thromb Haemost. 2003;1(3):433--8.
• Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: The LIVE--ENOX study. Thromb Haemost. 2005;3(2):227--9.
• Ogueh 0, Chen MF, Spurll G, Benjamin A. Outcome of pregnancy in women with hereditary thrombophilia. Int Gynaecol Obstet. 2001;74(3):247-53.
• Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006;22CD000112.